Designed for Doctors - CPD Accredited Course Bundles

This accredited course provides doctors with a comprehensive introduction to the clinical and regulatory foundations of medical cannabis prescribing in Australia. As patient interest in cannabinoid-based therapies increases, it is essential for prescribers to be equipped with evidence-informed knowledge and practical skills to navigate this evolving space safely and effectively. Through this program, participants will explore the endocannabinoid system and its relevance to human physiology, examine the pharmacology of key cannabis constituents, and gain practical insight into initiating, monitoring, and titrating medical cannabis products. The course also addresses the Australian regulatory landscape and offers guidance on assessing patient suitability, facilitating informed discussions, and applying critical safety considerations in clinical practice. Designed to support evidence-based decision-making, this course empowers doctors to responsibly consider medical cannabis as part of a broader, patient-centred approach to managing chronic symptoms and conditions. Preview this course by watching the video above. Estimated Duration: 5 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Describe cannabis medicines accurately and demonstrate an understanding of the individual chemical components of the plant. Demonstrate an understanding of endocannabinoid system function. Assess the suitability of cannabis treatments in various chronic disease states. Identify appropriate patient cohorts for medical cannabis treatment. Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management. Initiate, monitor and titrate cannabinoid medicines.  Apply critical safety considerations in patient-centred care. Navigate the regulatory frameworks surrounding medical cannabis provision in Australia. 

This course is an intermediate-level exploration of how to tailor medical cannabis treatment for patients by considering their prior exposure to cannabis (medical or otherwise). With a focus on identifying patients' exposure levels, doctors will learn to customise care and treatment to safely and effectively unlock the therapeutic benefits of medical cannabis. Over the course of 7 modules, discover cannabis’ interactions with the body, as well as the key identifiers, considerations and recommendations for offering safe and effective treatment. Examine the biological composition of cannabis and its pharmacological interactions with the body, gaining insight into how prior exposure affects tolerance and experience. This course forms part of a comprehensive learning path covering factors to consider when offering medical cannabis care and treatment. Preview this course by watching the video above. Estimated Duration: 6 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Identify cannabis’ biological constituents and explain their effects on the body Explain how the endocannabinoid system (ECS) maintains homeostasis and describe cannabis’ interactions with the ECS, including how exposure affects endocannabinoid tone Identify the 2 dimensions of prior cannabis exposure, and explain how to identify them in patients Explain how prior exposure may impact treatment goals and discuss considerations and recommendations for setting personalised treatment goals based on prior exposure Identify and describe common medical cannabis products and explain the considerations and recommendations for product selection based on prior cannabis exposure Discuss general recommendations for dosage and titration based on patient’s prior cannabis exposure

Designed for doctors, this course explores a range of health conditions that disproportionately affect people assigned female at birth and intersex individuals with female reproductive organs—many of which are historically under-recognised and undertreated. These conditions can significantly impact physical, mental, and reproductive health, often requiring nuanced, multidisciplinary approaches. With medical cannabis emerging as a potential adjunct for symptom management, this course provides evidence-based insights into its role across conditions including: Endometriosis Dysmenorrhoea Polycystic Ovary Syndrome (PCOS) Premenstrual Dysphoric Disorder (PMDD) Postpartum Depression (PPD) Breast, ovarian, and uterine cancers Perimenopause and menopause The course also addresses key safety considerations, including contraindications during pregnancy and lactation. Clinicians will leave with a deeper understanding of how to safely integrate medical cannabis into patient-centred care plans alongside conventional therapies. Preview this course by watching the video above. Estimated Duration: 5.5 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Describe and explain the causes, symptoms, effects, and risk factors for various reproductive health conditions, including perimenopause, menopause, breast, ovarian, and uterine cancers, dysmenorrhoea, endometriosis, polycystic ovarian syndrome (PCOS), premenstrual dysphoric disorder (PMDD), and postpartum depression (PPD) Identify and evaluate common conventional treatment options for these conditions and their potential drawbacks Discuss the therapeutic potential of medical cannabis for treating symptoms of these reproductive health conditions Identify considerations for selecting suitable medical cannabis products for treating symptoms related to these conditions Identify TGA guidelines on contraindications for medical cannabis use during pregnancy and chest-feeding Discuss potential short and long-term risks of early cannabis exposure Explain the role of the endocannabinoid system in reproductive function Describe the risks of cannabis use during pregnancy, planning to become pregnant, and postnatal phases for both the foetus or infant and the birth-giver